Correlation Between Ubiquiti Networks and Enlivex Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ubiquiti Networks and Enlivex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubiquiti Networks and Enlivex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ubiquiti Networks and Enlivex Therapeutics, you can compare the effects of market volatilities on Ubiquiti Networks and Enlivex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubiquiti Networks with a short position of Enlivex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubiquiti Networks and Enlivex Therapeutics.

Diversification Opportunities for Ubiquiti Networks and Enlivex Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Ubiquiti and Enlivex is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Ubiquiti Networks and Enlivex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enlivex Therapeutics and Ubiquiti Networks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubiquiti Networks are associated (or correlated) with Enlivex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enlivex Therapeutics has no effect on the direction of Ubiquiti Networks i.e., Ubiquiti Networks and Enlivex Therapeutics go up and down completely randomly.

Pair Corralation between Ubiquiti Networks and Enlivex Therapeutics

Allowing for the 90-day total investment horizon Ubiquiti Networks is expected to generate 0.71 times more return on investment than Enlivex Therapeutics. However, Ubiquiti Networks is 1.4 times less risky than Enlivex Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Enlivex Therapeutics is currently generating about -0.07 per unit of risk. If you would invest  14,398  in Ubiquiti Networks on August 24, 2024 and sell it today you would earn a total of  20,174  from holding Ubiquiti Networks or generate 140.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Ubiquiti Networks  vs.  Enlivex Therapeutics

 Performance 
       Timeline  
Ubiquiti Networks 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Ubiquiti Networks are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating forward indicators, Ubiquiti Networks demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Enlivex Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Ubiquiti Networks and Enlivex Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ubiquiti Networks and Enlivex Therapeutics

The main advantage of trading using opposite Ubiquiti Networks and Enlivex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubiquiti Networks position performs unexpectedly, Enlivex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enlivex Therapeutics will offset losses from the drop in Enlivex Therapeutics' long position.
The idea behind Ubiquiti Networks and Enlivex Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Transaction History
View history of all your transactions and understand their impact on performance